Business Wire

Fluence Launches RAZR Modular System to Support Diverse Vertical Farming and On-site Propagation Needs

Share

Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, today released its RAZR Modular System, the company’s newest LED solution for vertical farmers featuring market-leading efficacies of 2.6 µmol/J under Fluence’s PhysioSpec™ BROAD R3 white spectrum.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210615005453/en/

Fluence’s years of experience collaborating with vertical farmers have proven PhysioSpec™ BROAD R3 is the optimal spectrum choice for crop propagation and full-cycle cultivation for a multitude of leafy greens, microgreens, herbs and other vegetables. Under Fluence’s BROAD R3 spectrum, the newest RAZR system is 18% more efficient than previous generations. The RAZR Modular System’s mechanical mounting and electrical wiring are also highly configurable and easily integrate into various racking styles. The system’s flexible design makes it uniquely suited for scale in a vertical farming environment.

“Vertical farmers are fueling some of the greatest innovations in modern crop production,” said David Cohen, CEO of Fluence. “By simplifying the food supply chain, vertical farms can deliver fresh, nutritional produce to localized regions. These intricate cultivation facilities typically require custom, multilayer racking systems with specialized LED lighting solutions that can optimize plant development through various growth stages. Our RAZR Modular System not only reduces overall operational expenses through its efficient and configurable fixtures, but also offers a proven spectrum for propagation and vertical cultivation for leafy greens, microgreens, herbs and other vegetables.”

Fluence distributes its RAZR Modular System to vertical farmers directly and through partners such as Ecopromt, a leading greenhouse consultancy. Ecopromt’s cultivation experts have designed a fully integrated cart system featuring the RAZR Modular System as well as a proprietary irrigation system. Ecopromt’s integrated cart system has been installed in multiple vertical farms throughout Europe and the U.S.

“Our team has been designing, developing and growing under the most advanced cart systems for vertical farming for nearly a decade,” said Tom Jönsson, head of sales for Ecopromt. “Ecopromt’s fully integrated system is easy to install and built to scale as a vertical farm grows. Combined with our irrigation system and configurable design, RAZR’s modular capabilities provide homogenous light distribution across crops, enabling growers to produce consistent, high-quality plants under some of the industry’s most efficient lighting technology.”

Based in Brooklyn, New York, aquaponic vertical farm Upward Farms leverages Fluence’s RAZR Modular System to optimize growth cycles for several microgreen and baby green variants through different stages of cultivation.

“The RAZR system is flexible, efficient and powerful, which allowed us to quickly and seamlessly integrate it into our grow stacks,” said Ben Silverman, CTO of Upward Farms. “RAZR’s modular nature allows us to tailor the lights to our system while increasing efficiency and reducing grow time.”

For more information about the RAZR Modular System and Fluence’s extended portfolio of LED solutions, visit www.fluence.science.

About Fluence by OSRAM

Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM, creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. For more information about Fluence, visit https://fluence.science.

About Upward Farms

Upward Farms is a USDA-Certified Organic aquaponic vertical farm located in Brooklyn, NY. Upward Farms uses a breakthrough approach that marries modern vertical farming with the ancient practice of aquaponics. This method utilizes fish to fertilize crops in a complete ecosystem that relies on the naturally occurring microbiome, which is the superpower that has sustained life for millions of years. Upward Farms is dedicated to healing the broken food system & reconnecting eaters with flavorful, nutritious, local food. To learn more about Upward Farms, visit www.eatupwardfarms.com.

About Ecopromt

Ecopromt is a family-owned business that works in the horticulture sector, specialized in fresh herbs but also focuses on research and development on other crops. Ecopromt offers consultation on growing and technical advice, with a business strategy of combining biology, chemistry and automation so that growers around the world can get more effective with their crops. Ecopromt with its main office in Sweden is an official reseller of Fluence by OSRAM lights and manufacturer of our own integrated cart systems. Ecopromt also have a branch office in Harrisonburg, Virginia where we offer similar services.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For EMEA,
Silvia Nagyova
+49 (89) 6213-3939
s.nagyova@osram.com

For North America,
Emma Chase
emma@redfancommunications.com
512-917-4319

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye